Vagus nerve stimulation (VNS) for major depressive episodes: One year outcomes

Biological Psychiatry

Volumn 51, Issue 4, 2002, Pages 280-287

  Marangell, Lauren B ^a   Rush, A John ^b   George, Mark S ^c   Sackeim, Harold A ^d,e   Johnson, Christopher R ^a   Husain, Mustafa M ^b   Nahas, Ziad ^c   Lisanby, Sarah H ^d  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^e BCM 350 ^*  (United States)

Author keywords

Bipolar depression; Depression; Maintenance; Treatment; Treatment resistant; Vagus nerve stimulation

Indexed keywords

AMFEBUTAMONE; CARBAMAZEPINE; LAMOTRIGINE; LITHIUM; MIRTAZAPINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VENLAFAXINE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DEPRESSION; DYSPNEA; ELECTROCONVULSIVE THERAPY; FEMALE; FOLLOW UP; HAMILTON SCALE; HUMAN; LARYNX DISORDER; LONG TERM CARE; MALE; MENTAL FUNCTION; NECK PAIN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PSYCHOTHERAPY; REMISSION; SOCIAL STATUS; TREATMENT FAILURE; TREATMENT OUTCOME; VAGUS NERVE STIMULATION;

ADULT; COHORT STUDIES; DEPRESSIVE DISORDER; ELECTRIC STIMULATION THERAPY; ELECTRODES, IMPLANTED; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; TIME; TREATMENT OUTCOME; VAGUS NERVE;

EID: 0037084471     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(01)01343-9     Document Type: Article

References (34)

1. Vagus nerve stimulation for treatment of partial seizures: 1. A controlled study of effect on seizures
2. Loss of antidepressant efficacy during maintenance therapy: Possible mechanisms and treatments
3. Continuation therapy with amitriptyline in depression
4. Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures
5. Efficacy of venlafaxine and placebo during long-term treatment of depression: A pooled analysis of relapse rates
6. Three-year outcomes for maintenance therapies in recurrent depression
7. Comparison of full-dose versus half-dose pharmacotherapy in the maintenance treatment of recurrent depression
8. Efficacy of continuation ECT and antidepressant drugs compared with long-term antidepressants alone in depressed patients
9. Development of a rating scale for depression
10. Vagus nerve stimulation therapy for partial-onset seizures: A randomized active-control trial
11. A new depression scale designed to be sensitive to change
12. The prophylactic efficacy of fluoxetine in unipolar depression
13. Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression
14. Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy
15. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders
16. Placebos, drug effects, and study design: A clinician's guide
17. Loss of drug effects during continuation therapy
18. Vagus nerve stimulation (VNS) for treatment-resistant depressions: A multicenter study
19. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: A randomized controlled trial
20. The effects of vagus nerve stimulation on cognitive performance in patients with treatment-resistant depression
21. The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression
22. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy
23. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities
24. Vagus nerve stimulation (VNS) for treatment-resistant depression: Efficacy, side-effects, and predictors of outcome
25. Vagus nerve stimulation for the treatment of medically intractable seizures
26. The efficacy and safety of a new enteric-coated formulation of fluoxetine given once weekly during the continuation treatment of major depressive disorder
27. A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures
28. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection
29. A structured interview guide for the Hamilton Depression Rating Scale
30. A rating scale for mania: Reliability, validity and sensitivity